Release Date: November 27, 2024
Expiration Date: November 27, 2025
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in small cell lung cancer (SCLC). In this educational program, these experts engage in an interactive discussion on the evolving strategies in SCLC care. Key topics include the application of innovative therapeutic approaches, such as ADCs, bispecific antibodies, and novel treatments targeting DLL-3. This dynamic format explores ongoing challenges in SCLC management and discusses future clinical directions aimed at improving patient outcomes in real-world settings.
This educational activity is an archive of the live symposium held on November 15, 2024.
Target Audience
This educational activity is directed toward physicians, pathologists, advanced practice professionals, nurses, pharmacists, and other health care practitioners interested in SCLC.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate clinical trial evidence supporting the efficacy and safety of SCLC treatment across lines of care in real-world case-based scenarios
- Develop strategies to mitigate and manage treatment-related adverse events in patients with SCLC
- Evaluate the rationale for modifying standard treatment regimens in SCLC
- Integrate new data and emerging strategies into the treatment paradigm for both limited- and extensive-stage SCLC
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login HereAccreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-335-H01-P. The activity is available for CE credit through November 27, 2025.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Amgen.
